Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-06-15
1995-08-15
Prescott, Arthur C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514552, 554219, 554224, C09F 700, A01N 3700, A61K 3100
Patent
active
054419514
ABSTRACT:
Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. These small molecules are useful for treating vasoconstrictive, inflammatory, myeloid suppressive, cardiovascular, and gastrointestinal diseases.
REFERENCES:
patent: 4560514 (1985-12-01), Samuelsson et al.
patent: 4576758 (1986-03-01), Morris
patent: 4780281 (1988-10-01), Marnett et al.
patent: 5049681 (1991-09-01), Sato
patent: 5079261 (1992-01-01), Serhan et al.
patent: 5322699 (1994-06-01), Wright et al.
Fiore, et al. "Lipoxin Recognition Sites", The Journal of Biological Chemistry (1992), vol. 267, No. 23, pp. 16168-16176.
Serhan, "Lipoxins: Eicosanoids Carrying Intra- and Intercellular Messages", Journal of Bioenergetics and Biomembranes, (1991), vol. 23, No. 1, pp. 105-122.
Mizukami, et al., ".omega.-Hydroxylation of lipoxin B.sub.4 by human neutrophil microsomes: identification of .omega.-hydroxy metabolite of lipoxin B.sub.4 and catalysis by leukotriene B.sub.4 .omega.-hydroxylase (cytochrome P-450LTB.omega.)", Biochimica et Biophysica Acta (1993), No. 1168, pp. 87-93.
Popov, et al., "Effect of Lipoxin B on Colony-Forming Ability of Human Peripheral Blood Mononuclears in a Diffusion Chamber", Translated from Byulleten `Eksperimental` noi Biologii i Meditsiny, (1989), vol. 107, No. 1, pp. 80-83.
Katoh, et al., "Renal Hemodynamic Actions of Lipoxin in Rats: A Comparative Physiological Study", American Journal Physiology, (1992), vol. 263, pp. F436-F442.
Brady, et al., "Leukotrienes Stimulate Neutrophil Adhesion to Mesangial Cells: Modulation with Lipoxins", American Journal Physiology, (1990), vol. 259, pp. F809-F815.
Nigam, et al., "Lipoxin A.sub.4 and Lipoxin B.sub.4 Stimulate the Release but Not the Oxygenation of Arachidonic Acid in Human Neutrophils: Dissociation between Lipid Remodeling and Adhesion", Journal of Cellular Physiology, (1990), vol. 143, pp. 512-523.
Lee, et al., "Inhibition of Leukotriene B.sub.4 -Induced Neutrophil Migration by Lipoxin A.sub.4 : Structure-Function Relationships", Biochemical and Biophysical Research Communications, (1991), vol. 180, No. 3, pp. 1416-1421.
Nicolaou, et al., "Lipoxins and Related Eicosanoids: Biosynthesis, Biological Properties, and Chemical Synthesis", Angew, Chem. Int. Ed. Engl., (1991), vol. 30, pp. 1100-1116.
Nicolaou, et al., "Identification of a Novel 7-cis-11-trans-lipoxin A.sub.4 Generated by Human Neutrophils: Total Synthesis Spasmogenic Activities and Comparison with Other Geometric Isomers of Lipoxin A.sub.4 and B.sub.4 ", Biochimica et Biophysica Acta, (1989), No. 1003, pp. 44-53.
Nicolaou, et al., "Total Synthesis of Novel Geometric Isomers of Lipoxin A.sub.4 and Lipoxin B.sub.4 ", Reprint from The Journal of Organic Chemistry (1989), vol. 54, No. 23, pp. 5527-5535.
Brigham & Women's Hospital
Prescott Arthur C.
LandOfFree
Lipoxin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipoxin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipoxin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181913